Operating CF
$288M
Capex
-$36.9M
Free Cash Flow
$251M
FCF Margin
+87.2%
Cash flow waterfall for Teladoc Health (TDOC) — TTM through Q1 2026
Free cash flow: $251M
Note: Other Investing is large — driven mainly by purchases or sales of investments.
Cash flow breakdown for Teladoc Health (TDOC) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $288M | $288M |
| Capital Expenditure | -$36.9M | $251M |
| Free Cash Flow | $251M | $251M |
| Acquisitions | -$17.3M | $234M |
| Other Investing | -$125M | $109M |
| Net Debt Change | -$551M | -$442M |
| Other Financing & FX | -$662K | -$443M |
| Net Cash Decrease | -$443M | -$443M |
- Operating Cash Flow$288M
- Capital Expenditure-$36.9M
- Free Cash Flow$251M
- Acquisitions-$17.3M
- Other Investing-$125M
- Net Debt Change-$551M
- Other Financing & FX-$662K
- Net Cash Decrease-$443M
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Teladoc Health (TDOC) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
How this company returns cash to shareholders — buybacks, dividends, and stock splits.